股东权益报酬率(%) RoE | |
InMode L | 40.5 |
Fonar Co | 11.8 |
Electrom | 9.3 |
美敦力有限公司 | 8.6 |
Acutus M | 0 |
EDAP TMS | 0 |
Senseoni | 0 |
Cutera, | 0 |
Iridex C | 0 |
LivaNova | 0 |
Conmed C | 0 |
ReShape | 0 |
Heska Co | 0 |
Pacific | 0 |
Koninkli | 0 |
Anika Th | 0 |
Biomeric | 0 |
Cerus Co | 0 |
Glaukos | 0 |
iCAD, In | 0 |
Inspire | 0 |
Motus Gi | 0 |
Novocure | 0 |
Nevro Co | 0 |
Surmodic | 0 |
electroC | 0 |
AdaptHea | 0 |
Butterfl | 0 |
BioSig T | 0 |
Bioventu | 0 |
Cytek Bi | 0 |
现金与约当现金比率(%) | |
CVRx, In | 87.3 |
InMode L | 86.9 |
Motus Gi | 86.7 |
Movano I | 81.4 |
Talis Bi | 79.8 |
Novocure | 78.2 |
Inspire | 77.3 |
SI-BONE, | 75.5 |
Outset M | 73.4 |
RxSight, | 72.9 |
TELA Bio | 71.7 |
Tivic He | 71.4 |
electroC | 71.3 |
TransMed | 71.3 |
MaxCyte, | 70.9 |
Senseoni | 69.6 |
Cytek Bi | 63.1 |
Stereota | 62.5 |
Nevro Co | 60.2 |
Acutus M | 58.0 |
Nuwellis | 57.5 |
BioSig T | 56.2 |
Butterfl | 54.0 |
Inari Me | 53.6 |
Treace M | 51.8 |
EDAP TMS | 51.0 |
Lucid Di | 49.9 |
Cerus Co | 49.3 |
Pacific | 48.4 |
iCAD, In | 46.9 |
Cutera, | 44.2 |
营业毛利率(%) | |
MaxCyte, | 90.1 |
Inari Me | 89.3 |
SI-BONE, | 86.0 |
InMode L | 84.9 |
Inspire | 84.4 |
Axogen, | 81.9 |
Paragon | 80.5 |
Treace M | 80.4 |
BioSig T | 78.3 |
Novocure | 77.0 |
CVRx, In | 76.6 |
Electrom | 76.3 |
iCAD, In | 75.5 |
Glaukos | 74.4 |
Bioventu | 69.0 |
Nevro Co | 68.6 |
electroC | 68.0 |
Stereota | 67.5 |
美敦力有限公司 | 67.3 |
LivaNova | 66.9 |
ZimVie I | 65.3 |
TransMed | 64.4 |
TELA Bio | 63.9 |
Anika Th | 61.1 |
ReShape | 60.6 |
Cytek Bi | 57.1 |
Nuwellis | 55.0 |
Conmed C | 54.7 |
Cerus Co | 54.2 |
Cutera, | 53.5 |
Fonar Co | 48.4 |
营业利益率(%) | |
InMode L | 40.7 |
Fonar Co | 19.6 |
美敦力有限公司 | 18.7 |
Electrom | 9.8 |
Conmed C | 8.2 |
AdaptHea | 7.0 |
Koninkli | 3.7 |
Bioventu | 2.4 |
Cytek Bi | 2.2 |
Inari Me | 1.7 |
LivaNova | 0.1 |
Movano I | 0 |
Surmodic | -0.9 |
Heska Co | -1.8 |
Anika Th | -4.3 |
ZimVie I | -5.1 |
EDAP TMS | -7.7 |
Paragon | -7.9 |
Cutera, | -8.9 |
Novocure | -13.0 |
Treace M | -15.4 |
Iridex C | -17.1 |
Axogen, | -21.0 |
Nevro Co | -22.7 |
Inspire | -25.3 |
Glaukos | -33.9 |
iCAD, In | -35.6 |
Stereota | -45.4 |
Cerus Co | -45.5 |
SI-BONE, | -50.6 |
Owlet, I | -64.5 |
纯益率 / 净利率(%) | |
RxSight, | 1082.8 |
InMode L | 39.5 |
Fonar Co | 16.5 |
美敦力有限公司 | 14.4 |
Electrom | 7.6 |
Conmed C | 1.6 |
Koninkli | 0.7 |
Inari Me | 0.6 |
Movano I | 0 |
Cytek Bi | -2.1 |
Heska Co | -2.5 |
Surmodic | -3.1 |
AdaptHea | -7.0 |
EDAP TMS | -7.9 |
Anika Th | -10.2 |
ZimVie I | -10.2 |
Bioventu | -11.2 |
Paragon | -12.5 |
Novocure | -13.4 |
LivaNova | -14.4 |
Cutera, | -14.7 |
Iridex C | -15.8 |
Treace M | -19.1 |
Axogen, | -20.8 |
Nevro Co | -20.9 |
Inspire | -24.5 |
Glaukos | -28.3 |
Stereota | -42.8 |
iCAD, In | -45.1 |
Cerus Co | -50.5 |
SI-BONE, | -53.6 |
分红率(%) | |
美敦力有限公司 | 2.72 |
Conmed C | 0.8 |
Acutus M | 0 |
Cutera, | 0 |
electroC | 0 |
EDAP TMS | 0 |
Electrom | 0 |
Fonar Co | 0 |
Iridex C | 0 |
LivaNova | 0 |
Axogen, | 0 |
ReShape | 0 |
Heska Co | 0 |
Pacific | 0 |
Koninkli | 0 |
Anika Th | 0 |
Biomeric | 0 |
Cerus Co | 0 |
Glaukos | 0 |
iCAD, In | 0 |
Inspire | 0 |
Motus Gi | 0 |
Novocure | 0 |
Nevro Co | 0 |
Surmodic | 0 |
Senseoni | 0 |
AdaptHea | 0 |
Butterfl | 0 |
BioSig T | 0 |
Bioventu | 0 |
Cytek Bi | 0 |